SOURCE: Clinicares Inc.

April 26, 2007 01:03 ET

Clinicares Announces Appointment of New CEO

LOS ANGELES, CA -- (MARKET WIRE) -- April 26, 2007 -- Clinicares Inc. (PINKSHEETS: CCRC) announced today the appointment of Mr. James Songmoon Hong as Chief Executive Officer of the Company.

Mr. Hong's experience includes Director of Legal Affairs and Global Marketing at Biosys (which manufactures and sells medical appliances and equipment), Legal Affairs Director at Samhwa Networks, Legal Affairs and Global Marketing Director at KPNL and General Manager of its DNA examination center.

Mr. Hong's future vision of the company is summarized below.

Clinicares plans to sell its functional beauty products, Microneedle, CTS (Clinicares Treatment Solution), and related health products in the Korea, North America and Southeast Asia markets. After approval (imminent) of the beauty and food products by Korea's Food and Drug Administration, the company plans to increase its sales through Korean home shopping, dermatologists, cosmetic surgeries, skin care centers and the B2C market.

In addition, Clinicares plans to sell its DNA gene products and expertise in China (Clinicares is currently negotiating the details of this venture with the Chinese Officials). In this regard, Mr. Hong, the new CEO of Clinicares, has related experience and knowledge with DNA genes and is in a position to expand this business for the Company. The marketing strategy for the DNA gene business is to concentrate on wealthy people provided by the prevention of diseases, applications in the medical science-forecasting field, and applications in personalized cosmetic products. Clinicares expects significant sales in China, Korea, North America and Southeast Asia markets through this specialized DNA gene marketing strategy.

Clinicares and its new CEO, James Songmoon Hong, are forging ahead with its plans to establish a new laboratory to expand the DNA Gene business in the world markets.

About Clinicares:

Micro Roller and Peptide Product line:

With the conventional application of creams, gels or lotions only a fraction (less than 0.5%) of their active substances can penetrate the epidermal barrier (99.5% is lost). The upper skin layer, (epidermis) consists of several layers and their structure is like a brick-wall.

The Clinicares Micro Roller, studded with nearly 200 extreme fine needles of medical grade stainless steel with a tip length of 0.2mm, is the latest revolutionary cosmeceutical tool in skin care treatments. When applied to the surface of the skin, it creates deep micro channels in the layer of dead cells that normally protects the skin. These enable the active ingredients of peptide-based products to penetrate more deeply and in greater quantities than simply applying the preparation to the surface.

The "Soft" Alternative for all Common Laser & Peeling-Methods:

CTS (Clinicares Treatment Solutions) is a procedure, which stimulates the skin to produce a new collagen formation, thereby reducing wrinkles and improving skin texture. Clinicares Micro Roller is used to produce many microscopic channels in the skin, which stimulate your own body to produce new collagen. These channels improve (1000 times) the penetration of the highest concentration of peptides, vitamin creams, or any other liposomal serums. The Clinicares' peptide products, especially formulated to work with the Clinicares Micro Roller, stimulate skin renewal, which allows the skin to appear fresher, younger and with dramatically reduced fine lines and wrinkles. Clinicares Treatment Solutions (CTS) are longer lasting compared to artificial injected collagen.


Contact Information


    Clinicares Inc.
    8484 Wilshire Blvd.
    Beverly Hills, CA 90210
    Phone: 213-384-0500

    Halen Bach, President